HomeIPA • NASDAQ
add
Immunoprecise Antibodies Ltd
Previous close
$0.43
Day range
$0.43 - $0.47
Year range
$0.27 - $1.39
Market cap
20.98M USD
Avg Volume
1.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | 6.15M | -1.13% |
Operating expense | 6.58M | 0.72% |
Net income | -21.52M | -703.32% |
Net profit margin | -349.88 | -712.54% |
Earnings per share | — | — |
EBITDA | -2.40M | -18.37% |
Effective tax rate | 12.28% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.92M | 108.17% |
Total assets | 45.53M | -42.13% |
Total liabilities | 20.41M | -29.30% |
Total equity | 25.12M | — |
Shares outstanding | 45.77M | — |
Price to book | 0.78 | — |
Return on assets | -15.59% | — |
Return on capital | -18.87% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -21.52M | -703.32% |
Cash from operations | -1.20M | -16.57% |
Cash from investing | -112.00K | -296.49% |
Cash from financing | 10.55M | 1,620.39% |
Net change in cash | 9.38M | 4,972.43% |
Free cash flow | -77.25K | -109.20% |
About
Founded
1983
Headquarters
Website
Employees
87
